Ablation Frontiers

About:

A develops and markets cardiac ablation devices for the treatment of individuals suffering from atrial fibrillation.

Website: https://www.ablationfrontiers.com

Top Investors: Versant Ventures, Novartis Venture Fund, Aberdare Ventures, Hexagon Investments, Pequot Capital

Description:

Ablation Frontiers, Inc. (www.ablationfrontiers.com) is a medical device company based in Carlsbad, Calif., dedicated to helping individuals suffering from AF and other cardiac arrhythmias. In 2006, Ablation Frontiers received CE Mark to begin marketing its system of catheters and the GENius™ Radiofrequency (RF) Generator in the European Union to treat supraventricular arrhythmias and for use in atrioventricular node ablation. Ablation Frontiers is conducting a clinical trial under a United States Food and Drug Administration (FDA) investigational device exemption (IDE) to gain approval of the catheter system for permanent/long-standing persistent/chronic AF in the United States. Ablation Frontiers products are not approved for marketing or sales in the United States.